Background: Little is known concerning the precision of self-reported health economic data. Aim: To investigate the repeatability of self-reported health economic cost and utilization data in subjects with chronic obstructive pulmonary disease (COPD). Methods: Twelve weeks after inclusion, a physician and a nurse in random order interviewed 29 subjects with post-bronchodilator COPD included from a research registry of COPD patients. The interview recorded healthcare utilization and costs, sick leave, exacerbations and quality of life (QoL). Variation of individual agreement of observations was described estimating kappa statistics and 95% limits of agreement. Results: Mean age was 63 years (standard deviation (SD) 10) and 17 participants were men. Average FEV 1 % predicted was 56% (SD 15). For sick leave, exacerbation, healthcare provider visit, change of medication, assistance and leisure time the kappa values were 1.00, 0.73, 0.73, 0.66, 0.63 and 0.54, respectively. The physician recorded fewer days of exacerbation and fewer contacts with healthcare providers than the nurse (p Z 0.01 and p Z 0.05, respectively). The 95% limits of agreement for costs of drugs were À690 to þ710 Norwegian Kroner (NOK), À1200 to þ899 NOK for costs of healthcare providers and À20 to þ26 for QoL as measured by a visual analogue scale.
Introduction
Chronic obstructive pulmonary disease (COPD) is a globally widespread disease, causing considerable morbidity and mortality. 1, 2 In terms of economic impact, COPD imposes a large burden on the society as well as on the individual. 3, 4 COPD cost studies are usually based on register information, 5 or information provided by the patients themselves. 3 Register-based data are already available for large population groups. 5, 6 However, they cover only part of the true costs related to the disease. For instance are costs for help from unprofessional caregivers and over-the-countermedication often ignored, and subjects without a physician diagnosis are not included. 3 Self-reported information allows access to detailed personal costs, and thus cost estimates contain different information than those of registerbased studies. However, the quality of self-reported cost information by COPD patients has hardly been examined.
The validity of self-reported economic data has been compared to register data, showing that self-reports of hospital admissions are of higher validity than reports on healthcare provider contacts, and that the ability of patients to recall drug use may be unsatisfactory. 7 No information is available regarding the repeatability of cost items provided by patients in economic surveys. Such knowledge is important when interpreting the overall validity of health economic data on COPD.
In a pilot study of the economics of COPD in Norway, we evaluated questionnaires used in collecting data on healthcare utilization. The aim was to investigate the quality of self-reported health economic data as measured by the repeatability between two interviewers.
Material and methods
The study was conducted between December 2004 and March 2005. At baseline 30 COPD patients performed a post-bronchodilator spirometry. Twelve weeks later, subjects were in random order, twice interviewed by telephone by a physician and a nurse using the same questionnaire. Time interval between the two interviews was at least 3 days (mean 6 days, range 3e14 days). A flow chart of the design is shown in Fig. 1 . The Regional Committee for Medical Research Ethics of Western Norway approved the study.
Study population and sample
From a list of 40 COPD patients in a research registry, fulfilling a set of inclusion criteria, participants were recruited by telephone until 30 subjects had accepted the invitation and signed the informed consent. Four participants were not reached by phone, six refused participation because of disease and upcoming Christmas holidays.
There were three inclusion criteria. Firstly, all subjects were 40 years of age or above. Secondly, all participants had to be current or former smokers with a minimum of 2.5-pack years tobacco exposure. Thirdly, all participants had COPD GOLD stage 2 or more severe. 8 
Methods
A group of five physicians in pulmonary medicine and two health economists developed the interview questionnaires. Several questions were imported from the OLIN cost-of-illness study. 9 Questions were added from the Hordaland County Respiratory Health Survey questionnaire. 10 Quality of life (QoL) was registered using the Euroqol five dimensional questionnaire (EQ-5D) and visual analogue scale (VAS).
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Each participant was interviewed with the same questionnaire on two occasions. Subjects were not informed at the first interview that there was going to be a second one. The sequence of interviewers was decided by randomization.
The two interviewers were both 27 years old. The nurse was female, and the physician was male. The nurse had worked 2.5 years in the Department of Thoracic Medicine at Haukeland University Hospital. The physician had completed Medical School, but not his internship.
Variables
The 12 weeks surveillance questionnaire on costs of COPD comprised 12 separate sections covering disease activity, healthcare utilization, costs of COPD and QoL. Six categorical variables had five or more positive outcomes. Positive answers for categorical variables were also recorded for home oxygen treatment (2), pulmonary rehabilitation (2), changed job situation (2), change of profession (1), hospitalization due to COPD (1), hospitalization due to other conditions (1), complementary medicine (1), change of residence (1) and having a nebulizer at home (1) .
The six categorical variables and five continuous core variables were as follows. (1) Exacerbation, defined as selfreported worsening of two major symptoms (dyspnoea, increased sputum, changed colour of sputum), or one major symptom and any of the minor symptoms (runny/stuffed nose, wheezing, sore throat/cough, asthenia) (modified after Ref. weeks (irrespective of cause). (4) Costs of drugs were interviewer-recorded total costs of medication. (5) Healthcare provider visits recorded for ''asthma, COPD or worsening of respiratory symptoms''. (6) Number of contacts e a summation of all healthcare provider contacts (telephone, home visits, office visits). (7) Costs of contacts defined as interviewer-recorded total costs for all healthcare provider contacts. (8) Sick leave recorded for subjects in a paid job only, and only as due to ''asthma, COPD or worsening of respiratory symptoms''. (9) Assistance e help from home nursing services, housekeepers, family members or friends, or dinner delivery. (10) Loss of leisure time defined as more than 5 h lost per week due to ''asthma, COPD or worsening of respiratory symptoms.'' (11) VAS e the answer per telephone to the specific EQ-5D VAS question. See Appendix for questionnaire texts.
Statistics
From the 12 weeks interviews we chose to only analyze categorical variables with at least five positive outcomes, as few outcomes give less precision of estimates, and also Pearson Chi-Square requires at least five events in each cell. 13 When continuous variables were missing due to negative answers on entry questions, the variables were recoded to zero.
Frequencies were compared using chi-square tests and tests of equality of proportions. Means were compared using t-tests after assessing normality. Testeretest agreement for continuous outcomes was described using methods outlined by Bland and Altman. 14 This method implies generating the ''95% limits of agreement'' from the mean difference between two measurements and its standard deviation. The limits of agreement are illustrated by plotting the difference between two observations against the mean of the same observation differences. For categorical outcomes we have computed kappa values, classified according to Landis and Koch. 15 For all analyses p-values less than 0.05 were considered significant. All analyses were performed using Stata 9.2 for Windows (Stata Corp, College Station, TX).
Results
One participant withdrew the day after being included. The remaining 29 subjects completed the protocol ( Table 1) . The mean age (SD) was 63 (10) years, 59% were men and 48% were current smokers. The mean FEV 1 (SD) predicted was 56 (15)% (15), and 83% of the participants had either chronic cough or dyspnoea when climbing two flights of stairs or had more severe dyspnoea. There were no significant differences in any of the baseline characteristics of the participants when comparing proportions and averages by first interviewer.
Categorical outcomes
The average incidence of events per 12 weeks of the analyzed categorical variables varied from 33% to 75%. No significant difference in incidence was observed between the physician and the nurse (Table 2) . Kappa values for loss of leisure time showed moderate agreement (0.54), while exacerbation status, healthcare provider visits, change of medication and assistance showed substantial agreement (0.73, 0.73, 0.66 and 0.63, respectively). For sick leave the agreement was perfect.
When comparing the testeretest between first and second interview (that is, independent of interviewer), similar kappa values as above were obtained. 
Continuous outcomes
For continuous variables (Table 3 ), the differences according to the interviewers were significant for exacerbation days (p Z 0.01) and borderline significant for number of healthcare provider contacts (p Z 0.05). BlandeAltman plots show that the width of the 95% limits of agreement was 2100 Norwegian Kroner (NOK, V 255) for self-reported costs of healthcare provider contacts, 1400 NOK (V 170) for drug costs, 32 days for length of exacerbation, nine contacts with healthcare providers and 46 units on the EQ-5D VAS (Fig. 2) . The large ranges of values for number and costs of healthcare provider contacts were attributable to one participant reporting eight visits to a chiropractor due to obstructive lung diseases, which were taken into account by only one interviewer. Aiming to investigate effects of the interviewer-order we first stratified the sample according to first interviewer and compared information recorded by the physician with information recorded by the nurse (Table 4 ). This showed that the difference between reported number of days in exacerbation to the physician and to the nurse was significant only when the physician conducted the first interview. The effect of interviewer-order was also investigated by looking at intra-observer effects. We then found significant lower average cost of healthcare provider contacts in the group first interviewed by the physician compared to the group where the physician conducted the second interview (NOK 33.7 vs. NOK 157.1, p < 0.05, Table 4 ). No significant differences were observed for the other continuous outcomes in these analyses.
When comparing the testeretest between first and second interview (that is, independent of interviewer) no significant differences were observed. The widths of the 95% limits of agreement did not change by any substantial degree (results not shown).
Discussion
This study indicates that repeated measurements of categorical variables on self-reported exacerbation and healthcare utilization in COPD patients show substantial agreement (Cohen's kappa > 0.6). For self-reported costs there were no significant differences between the two measurements, but we observed wide 95% limits of agreement. Number of days with exacerbation and number of healthcare provider contacts were lower when recorded by a physician than by a nurse. When analyses were conducted comparing two interviews at a different time irrespective of observer, no systematic differences were found. To our knowledge this is the first study reporting repeatability of cost items derived from patients' selfreports.
Some methodological considerations are needed. Firstly, our findings were from a study with only 29 participants. The frequency of services like hospital admissions, home oxygen treatment and pulmonary rehabilitation was low, and we chose to emphasize events with an incidence of at least 17% (five out of 29 participants) per 12 weeks. The interviewers were of different professional background and sex. This might lead to different responses from the attendants. 16 A larger study, with more participants and interviewers would allow a more complete examination of interviewer effects. This would also enable multivariate analyses comparing possible predictors of disagreement like gender, age, socioeconomic status and severity of disease.
Secondly, the median time between the first and the second interview was 6 days. Some participants might have remembered their answer to the first interviewer. However, participants were not made aware of the upcoming second interview. Investigators of respiratory symptoms 10 and environmental exposures 17 have used shorter 10 and longer 17 time intervals when examining retest agreement, both revealing considerable variation. Thirdly, our participants were recruited from a population with a rather large proportion of subjects with FEV 1 % of predicted below 50%. This would imply high consumption of healthcare resources, compared with a healthier group. Remembering ''zero utilization'' might be easier than recalling how many visits were utilized the last 12 weeks in the present group. Validity studies have indicated decreased validity when excluding non-utilizing subjects. 18, 19 Studying a population with lower morbidity might have resulted in higher repeatability. Most literature on the validity of health economic selfreported data is comparisons to register-based information, with the latter as a gold standard. In a review of 47 studies, Evans et al. 7 listed four factors as main determinants of agreement. First the elapsed time for which the patient was to recollect information e the shorter the more accurate. Second, more salient events as hospitalizations are more likely to be remembered than, e.g. intermittent With longer periods the risk of recall bias increases and shorter intervals one would need more interviews and thus the study would be more costly. Contacts with healthcare providers and changes of medication are non-salient events, and numbers of days with specifically defined symptoms (exacerbations) are difficult to recall for subjects with many respiratory symptoms. However, as Ritter and coworkers have shown, self-reports may in a diseased population be more sensitive than registers, because the recordings of healthcare services will be more complete. 20 The repeatability of categorical data, judged by kappa statistics, was substantial. Kappa statistics are sensitive to frequency of events, 21 which makes comparison between studies and between different variables difficult. In our study, the two items with the lowest kappa values (loss of leisure time and assistance at home) were among the variables with lowest incidence (Table 2 ). Other investigators have shown similar trends for prevalence of respiratory symptoms. 10 The kappa values of sick leave and leisure time loss (1.00 and 0.54, respectively) with similar incidences, indicate that sick leave give more valid information than leisure time loss.
BlandeAltman methods describe the variability between repeated observations of continuous data, but leaves to the clinical investigator to decide if the limits of agreement are acceptable or not. 13 The physician recorded exacerbation days and number of healthcare provider contacts differently than the nurse. This might be a difference of individual interviewing style, but also might be attributed to subjects understating their disease when talking to a physician. 22 The days in exacerbation and number of healthcare provider contacts should be interpreted with caution with regard to precision of the estimates. If patients were asked about all contacts and specified the cause of these, omission of contacts due to misclassification of cause could have been avoided. The difference for drugs costs might have resulted from one interviewer recording drugs for other diseases than COPD while the other interviewer did not. If the differences in recordings of costs were extrapolated to annual costs the widths of the 95% limits of agreement would reach 8900 NOK (V 1080) per patient for the healthcare provider visits, and 6000 NOK (V 728) per patient for the drugs costs.
The present findings were used to develop a protocol for a large COPD cost-of-illness study in Norway, EconCOPD. For EconCOPD we plan to use official registry information for drug use and hospital admissions. All patients will be asked to bring their prescription drugs to the phone for follow-up interviews. We will hire nine interviewers to reduce vulnerability to individual interview style. Comprehensive written guidelines will be developed, and all interviewers will go through extensive training including lectures, role-plays and supervised interviews on COPD patients. The dangers of observer effects will be emphasized throughout the entire survey. To increase precision of estimates of low incidence events a large fraction of severely ill COPD patients will be recruited.
In summary, we found that the repeatability of frequent self-reported categorical events was acceptable in a health economic pilot survey of COPD patients. However, the physician recorded number of days in exacerbation and number of healthcare provider contacts differently than the nurse. The width of the 95% limits of agreement was large for reports on the patients' own financial expenses. This knowledge is important for researchers interpreting cost-of-illness studies and measures need to be taken to minimize the inter-observer effects.
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